SK

Savithri Kalluri

Director Director DIN 07189386
DIN 07189386 First appointment Jun 2015 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jun 2015
Shareholding value Locked Premium profile

About Savithri Kalluri

Data last updated:

Savithri Kalluri has 11 years in corporate governance. Formerly with 1 company, such as Medgenix Pharma India Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 07189386
Primary Designation Director
First Appointment 02 Jun 2015
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director02 Jun 20152015Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medgenix Pharma India Private Limited
Premium access

Shareholding and investment profile for Savithri Kalluri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Savithri Kalluri

Savithri Kalluri has 11 years in corporate governance. Formerly with 1 company, such as Medgenix Pharma India Private Limited. Engaged in General Business. Contributes to corporate operations.

Savithri Kalluri is associated with 0 companies as a director.

Savithri Kalluri has expertise in General Business.

Savithri Kalluri has 11 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available